相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agents
Vanessa Duong et al.
CANCER RESEARCH (2007)
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E
AJ Butt et al.
ENDOCRINE-RELATED CANCER (2005)
Use of PROTACS as molecular probes of angiogenesis
P Bargagna-Mohan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
XB Liao et al.
MOLECULAR CANCER THERAPEUTICS (2005)
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
KM Rau et al.
ENDOCRINE-RELATED CANCER (2005)
Chemical genetic control of protein levels: Selective in vivo targeted degradation
JS Schneekloth et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Inhibiting proteasomal proteolysis sustains estrogen receptor-α activation
MY Fan et al.
MOLECULAR ENDOCRINOLOGY (2004)
Androgen receptors in prostate cancer
ZR Culig et al.
JOURNAL OF UROLOGY (2003)
Arginine-based molecular transporters: The synthesis and chemical evaluation of releasable taxol-transporter conjugates
TA Kirschberg et al.
ORGANIC LETTERS (2003)
Mitogen-activated protein kinase pathway is involved in androgen-independent PSAGene expression in LNCaP cells
OE Franco et al.
PROSTATE (2003)
Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-α protein:: Estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary
ET Alarid et al.
ENDOCRINOLOGY (2003)
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
SF Doisneau-Sixou et al.
ENDOCRINE-RELATED CANCER (2003)
Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling
G Reid et al.
MOLECULAR CELL (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer
AU Buzdar
ONCOLOGIST (2003)
Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-α
MT Preisler-Mashek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor
IE Eder et al.
CANCER GENE THERAPY (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
AL Wijayaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
DM Lonard et al.
MOLECULAR CELL (2000)
分享论文
